Literature DB >> 20347391

TRPV1 in migraine pathophysiology.

Jannis E Meents1, Lars Neeb, Uwe Reuter.   

Abstract

Migraine is among the most prevalent headache disorders and results from dysfunctions within the trigeminovascular system (TVS). The inflammatory processes that have been suggested to occur in the cascade of events resulting in migraine sensitise trigeminal nociceptors, possibly causing hyperalgesia and allodynia. Trigeminal nociceptors express the heat- and capsaicin-gated channel TRPV1, which seems to play a significant role in the development of peripheral and central sensitisation and of hyperalgesia and allodynia. Here, we review the molecular mechanisms leading to the sensitisation of TRPV1 and attempt to link them to migraine-relevant pathophysiological processes. We argue that antagonising TRPV1 sensitisation is a promising approach and should receive more attention in future research as well as in the development of anti-migraine drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347391     DOI: 10.1016/j.molmed.2010.02.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  32 in total

1.  Sumatriptan inhibits TRPV1 channels in trigeminal neurons.

Authors:  Miles Steven Evans; Xiangying Cheng; Joseph A Jeffry; Kimberly E Disney; Louis S Premkumar
Journal:  Headache       Date:  2012-01-30       Impact factor: 5.887

Review 2.  Calcium Channels in Vascular Smooth Muscle.

Authors:  D Ghosh; A U Syed; M P Prada; M A Nystoriak; L F Santana; M Nieves-Cintrón; M F Navedo
Journal:  Adv Pharmacol       Date:  2016-10-14

Review 3.  The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches.

Authors:  Mária Dux; Péter Sántha; Gábor Jancsó
Journal:  Pflugers Arch       Date:  2012-08-09       Impact factor: 3.657

4.  Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.

Authors:  Carrie V Vause; Paul L Durham
Journal:  Headache       Date:  2011-12-08       Impact factor: 5.887

Review 5.  Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model.

Authors:  Linde Buntinx; Steve Vermeersch; Jan de Hoon
Journal:  Br J Clin Pharmacol       Date:  2015-10-06       Impact factor: 4.335

Review 6.  Role of Omics in Migraine Research and Management: A Narrative Review.

Authors:  Pragya Chaturvedi; Rahul Khan; Prachi Sahu; Abhilash Ludhiadch; Gagandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

7.  The α6 subunit-containing GABAA receptor: A novel drug target for inhibition of trigeminal activation.

Authors:  Pi-Chuan Fan; Tzu-Hsuan Lai; Chia Chun Hor; Ming Tatt Lee; Pokai Huang; Werner Sieghart; Margot Ernst; Daniel E Knutson; James Cook; Lih-Chu Chiou
Journal:  Neuropharmacology       Date:  2018-07-21       Impact factor: 5.250

8.  Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury.

Authors:  Melanie B Elliott; Michael L Oshinsky; Peter S Amenta; Olatilewa O Awe; Jack I Jallo
Journal:  Headache       Date:  2012-05-08       Impact factor: 5.887

9.  TRPV1 (Transient Receptor Potential Vanilloid 1) Sensitization of Skeletal Muscle Afferents in Type 2 Diabetic Rats With Hyperglycemia.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Jere H Mitchell; Scott A Smith; Wanpen Vongpatanasin; Masaki Mizuno
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 10.190

10.  The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1).

Authors:  Swathi K Hullugundi; Michel D Ferrari; Arn M J M van den Maagdenberg; Andrea Nistri
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.